Home > Events > Town Hall with CEO@FPSK – Dr Rebecca Tay

Dr Rebecca Tay Appointed as the CEO@FPSK, UPM

On behalf of Precision Diagnostics, we proudly congratulate Dr. Rebecca Tay Sook Hui, Chief Executive Officer of Global Precision Diagnostics, on her appointment as the Chief Executive Officer of Faculty of Medicine and Health Sciences at Universiti Putra Malaysia (CEO FPSK) (UPM) for the year of 2024 and 2025.

CEO, Faculty of Medicine & Health Sciences, Dr Rebecca Tay
CEO, Faculty of Medicine & Health Sciences, Dr Rebecca Tay

This appointment reflects Dr. Rebecca’s extensive experience and leadership in advancing precision medicine, medical innovation and healthcare development. Through this role, she will contribute her industry insights and expertise to support closer engagement between academia and the healthcare sector, fostering greater collaboration, knowledge exchange and innovation.

As a strong advocate for the advancement of precision medicine, Dr. Rebecca has been actively involved in promoting the clinical application of pharmacogenomics and personalised healthcare. Her appointment further reflects a shared commitment to strengthening connections between academic research, healthcare education and real-world clinical practice.

Precision Diagnostics is proud to celebrate this meaningful achievement and looks forward to Dr. Rebecca’s continued contributions towards advancing healthcare, research and innovation in Malaysia.

About Universiti Putra Malaysia (UPM)

Universiti Putra Malaysia (UPM) is one of Malaysia’s leading public research universities, recognised for its excellence in education, research and innovation. The university offers a wide range of programmes across medicine, health sciences, science, technology, agriculture and other disciplines, while actively contributing to research and knowledge advancement in Malaysia and beyond.

About Precision Diagnostics

Precision Diagnostics is a precision medicine and genomic diagnostics organisation committed to translating advances in genomics into clinically meaningful healthcare solutions supported by clinical governance. Through its work in pharmacogenomics, precision oncology, genomic testing, clinical implementation, and international scientific collaboration, Precision Diagnostics aims to support safer, more personalised, and evidence-based patient care across Malaysia and the Asia-Pacific region.